Results of base-case analysis for mass screening for Singapore Chinese Males (50–75 years)
| Cohort size31 | 482 469 |
| Total no of gastric cancer patients in the cohort | 7241 |
| Compliance | 45% |
| Screened | Not screened | |
| No of subjects | 217 111 | 265 358 |
| Stage of diagnosis | 26%: 17%: 24%: 32% | 18%: 12%: 27%: 43% |
| Stage1:2:3:4 | ||
| Among those compliant to mass screening | ||
| No of miRNA tests done to diagnose one gastric cancer patient | 489 | |
| No of endoscopes done to diagnose one gastric cancer patient | 227 | |
| Cost of saving 1 QALY* (US$) | 44 531 | |
*Relative to the current practice of no-screening.
miRNA, microRNA; QALY, quality-of-life year.